Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Intravenous Immunoglobulin (IVIg) market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Intravenous Immunoglobulin (IVIg) market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Intravenous Immunoglobulin (IVIg) market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Intravenous Immunoglobulin (IVIg) products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Intravenous Immunoglobulin (IVIg) products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Intravenous Immunoglobulin (IVIg) market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Intravenous Immunoglobulin (IVIg) development has been the leading industry trend of Intravenous Immunoglobulin (IVIg) market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Intravenous Immunoglobulin (IVIg) Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
IVIG Liquid,IVIG Powder, Other |
| By Application Outlook |
Immunodeficiency,Autoimmune Disease,Acute Infection, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Baxalta,Grifols,CSL,Octapharma,Kedrion,BPL |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Baxalta
- Grifols
- CSL
- Octapharma
- Kedrion
- BPL
Intravenous Immunoglobulin (IVIg) Market, By Type
- IVIG Liquid
- IVIG Powder
- Other
Intravenous Immunoglobulin (IVIg) Market, By Application
- Immunodeficiency
- Autoimmune Disease
- Acute Infection
- Other
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
Global Intravenous Immunoglobulin (IVIg) Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Intravenous Immunoglobulin (IVIg) Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 IVIG Liquid Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 IVIG Powder Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Intravenous Immunoglobulin (IVIg) Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Intravenous Immunoglobulin (IVIg) Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Intravenous Immunoglobulin (IVIg) Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Intravenous Immunoglobulin (IVIg) Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Intravenous Immunoglobulin (IVIg) Market Assessment by Type
8.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Assessment by Application (Consumption and Market Share)
8.2 North America Intravenous Immunoglobulin (IVIg) Market Assessment by Application (Consumption and Market Share)
8.3 Europe Intravenous Immunoglobulin (IVIg) Market Assessment by Application (Consumption and Market Share)
8.4 South America Intravenous Immunoglobulin (IVIg) Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Baxalta
9.1.1 Baxalta Profiles
9.1.2 Baxalta Product Portfolio
9.1.3 Baxalta Intravenous Immunoglobulin (IVIg) Business Performance
9.1.4 Baxalta Intravenous Immunoglobulin (IVIg) Business Development and Market Status
9.2 Grifols
9.2.1 Grifols Profiles
9.2.2 Grifols Product Portfolio
9.2.3 Grifols Intravenous Immunoglobulin (IVIg) Business Performance
9.2.4 Grifols Intravenous Immunoglobulin (IVIg) Business Development and Market Status
9.3 CSL
9.3.1 CSL Profiles
9.3.2 CSL Product Portfolio
9.3.3 CSL Intravenous Immunoglobulin (IVIg) Business Performance
9.3.4 CSL Intravenous Immunoglobulin (IVIg) Business Development and Market Status
9.4 Octapharma
9.4.1 Octapharma Profiles
9.4.2 Octapharma Product Portfolio
9.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Business Performance
9.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Business Development and Market Status
9.5 Kedrion
9.5.1 Kedrion Profiles
9.5.2 Kedrion Product Portfolio
9.5.3 Kedrion Intravenous Immunoglobulin (IVIg) Business Performance
9.5.4 Kedrion Intravenous Immunoglobulin (IVIg) Business Development and Market Status
9.6 BPL
9.6.1 BPL Profiles
9.6.2 BPL Product Portfolio
9.6.3 BPL Intravenous Immunoglobulin (IVIg) Business Performance
9.6.4 BPL Intravenous Immunoglobulin (IVIg) Business Development and Market Status
10 World Intravenous Immunoglobulin (IVIg) Market Assessment by Players
10.1 Global Intravenous Immunoglobulin (IVIg) Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Intravenous Immunoglobulin (IVIg) Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Intravenous Immunoglobulin (IVIg) Price (USD/Unit) of Players 2014-2020
10.4 Global Intravenous Immunoglobulin (IVIg) Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Intravenous Immunoglobulin (IVIg) Sales Assessment of Players 2014-2020
11.1.2 North America Intravenous Immunoglobulin (IVIg) Revenue Assessment of Players 2014-2020
11.1.3 North America Intravenous Immunoglobulin (IVIg) Price Assessment of Players 2014-2020
11.1.4 North America Intravenous Immunoglobulin (IVIg) Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Intravenous Immunoglobulin (IVIg) Sales Assessment of Players 2014-2020
11.2.2 Europe Intravenous Immunoglobulin (IVIg) Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Intravenous Immunoglobulin (IVIg) Price Assessment of Players 2014-2020
11.2.4 Europe Intravenous Immunoglobulin (IVIg) Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Intravenous Immunoglobulin (IVIg) Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Intravenous Immunoglobulin (IVIg) Sales Assessment of Players 2014-2020
11.4.2 South America Intravenous Immunoglobulin (IVIg) Revenue Assessment of Players 2014-2020
11.4.3 South America Intravenous Immunoglobulin (IVIg) Price Assessment of Players 2014-2020
11.4.4 South America Intravenous Immunoglobulin (IVIg) Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Intravenous Immunoglobulin (IVIg) Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Intravenous Immunoglobulin (IVIg) Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Intravenous Immunoglobulin (IVIg) Sales by Countries/Regions 2014-2020
12.2.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Countries/Regions 2014-2020
12.2.3 North America Intravenous Immunoglobulin (IVIg) Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Countries/Regions 2014-2020
12.3.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Countries/Regions 2014-2020
12.3.3 Europe Intravenous Immunoglobulin (IVIg) Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Intravenous Immunoglobulin (IVIg) Sales by Countries/Regions 2014-2020
12.4.2 South America Intravenous Immunoglobulin (IVIg) Revenue by Countries/Regions 2014-2020
12.4.3 South America Intravenous Immunoglobulin (IVIg) Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Intravenous Immunoglobulin (IVIg) Sales & Revenue Forecast 2021-2026
14.1 World Intravenous Immunoglobulin (IVIg) Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Intravenous Immunoglobulin (IVIg)Sales and Market Share by Regions
14.1.2 World Intravenous Immunoglobulin (IVIg)Revenue and Market Share by Regions
15 Asia Intravenous Immunoglobulin (IVIg) Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 IVIG Liquid
15.1.2 IVIG Powder
15.2 Consumption Forecast by Application, 2021-2026
16 North America Intravenous Immunoglobulin (IVIg) Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 IVIG Liquid
16.1.2 IVIG Powder
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Intravenous Immunoglobulin (IVIg) Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 IVIG Liquid
17.1.2 IVIG Powder
17.2 Consumption Forecast by Application, 2021-2026
18 South America Intravenous Immunoglobulin (IVIg) Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 IVIG Liquid
18.1.2 IVIG Powder
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 IVIG Liquid
19.1.2 IVIG Powder
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Intravenous Immunoglobulin (IVIg) Price (USD/Unit) Trend 2021-2026
20.2 Global Intravenous Immunoglobulin (IVIg) Gross Profit Trend 2021-2026
21 Conclusion
